Grace Therapeutics, Inc. (GRCE) stock
GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
$1.81+0.00 (0.00%)
Close on Nov 13, 2026Market cap $38.08MP/E –Yield –
Grace Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Grace Therapeutics's price to book ratio was 0.6× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.2× to 1.1×, with a median of 0.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | −0.2 |
| 2025 | Dec 31, 2025 | 0.8× | +0.0 |
| 2024 | Dec 31, 2024 | 0.8× | +0.4 |
| 2023 | Dec 29, 2023 | 0.3× | +0.1 |
| 2022 | Dec 30, 2022 | 0.3× | −0.0 |
| 2021 | Dec 31, 2021 | 0.3× | −3.1 |
| 2020 | Dec 31, 2020 | 3.4× | – |
See a number that looks wrong?